A vascular bypass or vascular graft refers to surgical procedure performed to redirect blood flow from one area to another by reconnecting blood vessels. This is done to bypass a diseased artery, from an area of normal blood flow to another area of relatively normal blood flow. It is generally performed because of inadequate blood flow caused by atherosclerosis, as a part of organ transplantation, or for vascular access in hemodialysis.
Asia Pacific Vascular Graft Treatment Market is worth USD xx million in 2018 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2023. The Asia Pacific Vascular Graft Treatment market is developing at an exceptionally quick pace.
Increase in vascular disorders, high blood sugar, hypertension, and other risk factors are the major driving factors. Also factors like junk food, tobacco consumption, substance abuse, alcohol addiction has further propelled the market growth. However, high cost of treatment, and complications associated with prosthetic grafts are a major restraint.
The Asia Pacific Vascular Graft Treatment market is segmented on the basis of Raw Material, Product, End User and region. Based on Raw Material the market is segmented into Polyurethane, Polyester, Polytetrafluoroethylene (PTFE), and Biosynthetic. Polyester based grafts dominate the market due to factors like easy availability of raw material, high tensile strength and durability .Based on Product the market is segmented into Peripheral Vascular Graft, Hemodialysis Access Graft and Endovascular Aneurysm Repair Stent Graft. Endovascular Aneurysm Repair Stent Graft is further segmented into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Endovascular stent grafts segment accounted for the largest share owing to life style & occupational factors, consumption of high calorie junk food, alcohol, tobacco & substance abuse. Based on End User the market is segmented into Hospitals and Ambulatory Surgical Centers.
Asia Pacific is geographically segmented into China, India, Japan and South East Asia. Asia Pacific is the fastest growing region owing to increase in chronic diseases, growing medical tourism activities and increase in public and private healthcare expenditure.
Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V.B. Braun Melsungen AG, & Co. KG, Medtronic plc, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Terumo Corporation, and W. L. Gore & Associates, Inc. are the key players in the Asia Pacific Vascular Graft Treatment market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Peripheral Vascular Graft
5.1.3 Endovascular Aneurysm Repair Stent Grafts
5.1.4 Hemodialysis Access Graft
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Raw Material
5.2.1 Introduction
5.2.2 Biosynthetic
5.2.3 Polyester
5.2.4 Polyurethane (PU)
5.2.5 Polytetrafluoroethylene (PTFE)
5.2.6 Y-o-Y Growth Analysis, By Raw Material
5.2.7 Market Attractiveness Analysis, By Raw Material
5.2.8 Market Share Analysis, By Raw Material
5.3 End User
5.3.1 Introduction
5.3.2 Ambulatory Surgical Centers
5.3.3 Hospitals
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
5.4 Applications
5.4.1 Introduction
5.4.2 Coronary Artery Disease
5.4.3 Aneurysm
5.4.4 Vascular Occlusion
5.4.5 Renal Failure
5.4.6 Others
5.4.7 Y-o-Y Growth Analysis, By Applications
5.4.8 Market Attractiveness Analysis, By Applications
5.4.9 Market Share Analysis, By Applications
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Raw Material
6.1.3.4 By End User
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Raw Material
6.1.4.4 By End User
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Raw Material
6.1.5.4 By End User
6.1.5.5 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Cardinal Health Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 B. Braun Melsungen AG
8.3 Cook Medical Inc.
8.4 MAQUET Holding B.V.& Co.
8.5 Medtronic plc
8.6 Terumo Corporation
8.7 W. L. Gore & Associates, Inc.
8.8 LeMaitre Vascular
8.9 Endologix Inc.
8.10 C. R. Bard, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
